 |
|
|
|
|
|
 |
 |
 |
 |
 |
 |
|
||||||||||||||||||||
Title: |
Efficacy of Letrozole in Ovulation Induction Compared to That of Clomiphene Citrate in Patients with Polycystic Ovarian Syndrome | |||||||||||||||||||
| Authors: | Mahtab Zeinalzadeh, M.D., Zahra Basirat, M.D., and Mahsa Esmailpour, M.D. | |||||||||||||||||||
|
OBJECTIVE: To compare the efficacy of letrozole with clomiphene citrate for ovulation induction in patients with polycystic ovarian syndrome (PCOS).
STUDY DESIGN: In this clinical trial, 107 infertile patients with PCOS received either 100 mg clomiphene citrate (n=57) or 5 mg letrozole (n=50) daily since day 3–7 of their menstrual cycle. Human chorionic gonadotropin (hCG) was administered at a dose of 10,000 IU when at least 1 mature follicle was detected. A single intrauterine insemination was performed 34 hours later. Then the size, number and growth rate of follicles, ovulation rate, endometrial thickness and pregnancy rate were measured in both groups. RESULTS: The number and the size of mature follicles were similar between the 2 groups. The pregnancy rate in letrozole group was higher than that in the clomiphene group (20% vs. 14%), but the difference was not significant (p=0.286). In letrozole group, 86% of patients developed mature follicles, all showing ovulation, whereas 72% of patients in clomiphene citrate group developed mature follicles (p=0.07). CONCLUSION: Letrozole might be an acceptable alternative to clomiphene citrate to induce ovulation and pregnancy in PCOS patients. (J Reprod Med 2010;55: 36–40) |
||||||||||||||||||||
| Keywords: | clomiphene citrate, infertility, letrozole, polycystic ovary syndrome | |||||||||||||||||||
| Acrobat Reader 7.0 is recommended to properly view and print the article.
Reader can be downloaded from  |
||||||||||||||||||||
